Mass Spectrometric Evaluation of β-Cyclodextrins as Potential Hosts for Titanocene Dichloride.

Int J Mol Sci

Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, 3012 Bern, Switzerland.

Published: September 2021

Bent metallocene dichlorides (CpMCl, M = Ti, Mo, Nb, …) have found interest as anti-cancer drugs in order to overcome the drawbacks associated with platinum-based therapeutics. However, they suffer from poor hydrolytic stability at physiological pH. A promising approach to improve their hydrolytic stability is the formation of host-guest complexes with macrocyclic structures, such as cyclodextrins. In this work, we utilized nanoelectrospray ionization tandem mass spectrometry to probe the interaction of titanocene dichloride with β-cyclodextrin. Unlike the non-covalent binding of phenylalanine and oxaliplatin to β-cyclodextrin, the mixture of titanocene and β-cyclodextrin led to signals assigned as [βCD + CpTi-H], indicating a covalent character of the interaction. This finding is supported by titanated cyclodextrin fragment ions occurring from collisional activation. Employing di- and trimethylated β-cyclodextrins as hosts enabled the elucidation of the influence of the cyclodextrin hydroxy groups on the interaction with guest structures. Masking of the hydroxy groups was found to impair the covalent interaction and enabling the encapsulation of the guest structure within the hydrophobic cavity of the cyclodextrin. Findings are further supported by breakdown curves obtained by gas-phase dissociation of the various complexes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467183PMC
http://dx.doi.org/10.3390/ijms22189789DOI Listing

Publication Analysis

Top Keywords

titanocene dichloride
8
hydrolytic stability
8
hydroxy groups
8
mass spectrometric
4
spectrometric evaluation
4
evaluation β-cyclodextrins
4
β-cyclodextrins potential
4
potential hosts
4
hosts titanocene
4
dichloride bent
4

Similar Publications

The reduction of titanocene dichloride CpTiCl with lanthanide metals has led to the discovery of a surprising lanthanide effect: while with most lanthanides, a divalent [CpTi] equivalent was obtained, the use of samarium or ytterbium only led to the reduction to trivalent [CpTiCl]-type complexes, including the structurally characterized heterobimetallic complex [CpTi(μ-Cl)SmCl(THF)]. These results were corroborated by reactivity studies (alkyne coupling and radical reactions), EPR spectroscopy and electrospray mass spectrometry, providing new insights into the reduction chemistry of lanthanide metals.

View Article and Find Full Text PDF

A Comprehensive Review on the Development of Titanium Complexes as Cytotoxic Agents.

Curr Top Med Chem

October 2024

Department of Chemistry, National Institute of Technology, Hamirpur, Himachal Pradesh, 177005, India.

After the discovery of cis-platin, the first metal-based anticancer drugs, budotitane, and titanocene dichloride entered clinical trials. These two classes of complexes were effective against those cell lines that are resistant to cis-platin and other platinum-based drugs. However, the main limitation of these complexes is their low hydrolytic stability.

View Article and Find Full Text PDF

Anti-tumoral Titanium Complexes Stabilized with Phenolato Ligands and Structure-Activity Relationship.

Curr Top Med Chem

August 2023

Fachbereich Chemie and Konstanz Research School Chemical Biology, Universität Konstanz, Universitätsstr, 10, D-78457, Konstanz, Germany.

Titanocene dichloride and budotitane have opened a new chapter in medicinal chemistry of titanium complexes being novel non-platinum antitumor metallic agents. Numerous efforts have led to the discovery of the diamino -phenolato titanium complexes. Among which, the [ONNO] and [ONON] type ligands namely Salan, Salen and Salalen coordinated titanium alkoxyl complexes have demonstrated significantly enhanced aqueous stability, their and antitumor efficacy, mechanism of action, structure-activity relationships and combined tumor therapy have been intensively investigated.

View Article and Find Full Text PDF

The search for new anticancer drugs based on biogenic metals, which have weaker side effects compared to platinum-based drugs, remains an urgent task in medicinal chemistry. Titanocene dichloride, a coordination compound of fully biocompatible titanium, has failed in pre-clinical trials but continues to attract the attention of researchers as a structural framework for the development of new cytotoxic compounds. In this study, a series of titanocene (IV) carboxylate complexes, both new and those known from the literature, was synthesized, and their structures were confirmed by a complex of physicochemical methods and X-ray diffraction analysis (including one previously unknown structure based on perfluorinated benzoic acid).

View Article and Find Full Text PDF

Metal-based complexes have occupied a pioneering niche in the treatment of many chronic diseases, including various types of cancers. Despite the phenomenal success of cisplatin for the treatment of many solid malignancies, a limited number of metallo-drugs are in clinical use against cancer chemotherapy till date. While many other prominent platinum and non‑platinum- based metallo-drugs (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!